Oslo, Norway, 21 October 2021
Vistin Pharma ASA will release its third quarter 2021 results on Thursday 28(th)
of October 2021. Vistin Pharma will host a conference call for all shareholders
and interested parties on Thursday 28(th) of October at 08:30 CET. There will be
a Q&A session following the management discussion.
The conference call will be held in English.
The third quarter conference call will be available via web and audio through
the following access points:
Telephone conference:
Confirmation Code: 1860729
International dial-In: +44 (0) 2071 928338
Norway, Oslo: +47 21563015
United States, New York: +1 6467413167
Webcast:
https://edge.media-server.co (https://edge.media-server.com/mmc/p/u59e5tiq)m
(https://edge.media-server.com/mmc/p/u59e5tiq)/mmc/p/u59e5tiq
(https://edge.media-server.com/mmc/p/u59e5tiq)
*****
For further information, please contact:
Alexander Karlsen
CFO
+47 97053621
alexander.karlsen@vistin.com (mailto:alexander.karlsen@vistin.com)
About Vistin Pharma | www.vistin.com
Vistin Pharma is a Norwegian pharmaceutical company producing Metformin
Hydrochloride (API). The Metformin is also available as Direct Compressible
lubricated granules. As a solely dedicated European Metformin producer, Vistin
Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin
Pharma is headquartered in Oslo, Norway, and has highly qualified employees and
a dedicated manufacturing facility in Kragerø.